Risk of CNS relapse by CNS-IPI and COO (CNS-IPI-C) in the COO available population (n = 933). EoT, end of treatment; H-R, high risk; I-R, intermediate risk; L-R, low risk; UNCL, unclassified. See Figure 2 in the article by Klanova et al that begins on page 919.